bromopyruvic acid glutathione adduct Synthesis and anticancer activity of Pt(iv) prodrugs containing 3-bromopyruvic as an axial ligand Rewiring of mitochondrial metabolism in – 3-Bromopyruvate overcomes cetuximab resistance in
3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation Experimental and Therapeutic Medicine
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



